National and Kapodistrian University of Athens
Αλλαγές στην έκφραση τύπων κολλαγόνου που σχηματίζουν ινίδια στον μη-μικροκυτταρικό καρκίνο του πνεύμονα
Abstract
dc:descriptionPurpose: Research concerning the molecular mechanisms of non-small cell lung cancer (NSCLC) development may provide biological markers for novel diagnostic and therapeutic strategies. Invasion of the extracellular matrix (ECM) is a crucial hallmark in tumor metastasis.It has been shown that the expression of collagen changes in malignancies, especially that of collagen XI. This would affect the ability of cancer cells to invade the stroma and metastasize. The a1 chain of collagen XI is transcribed from COL11A1 gene by alternative splicing in at least four different transcripts (termed A, B, C and E). The corresponding protein isoforms differ in the proteolysis of the N-terminus and potentially, in the way that mediate invasion in the extracellular matrix. The purpose of the study was the development of new quantitative methodologies for the general (total) COL11A1 and the C transcript (RT-qPCR methods for A and E transcripts have already been developed by our group previously), the quantification of all COL11A1 transcripts in Non Small Cell Lung Cancer and the investigation for the first time of their potential association with histopathological prognostic factors in lung cancer.Methods: Surgical lung samples from 23 patients with NSCLC and 6 patients without cancer (control group) were taken from the tumor site in cancer patients and healthy normal lung site in the control group. Real-time quantitative RT-PCR was performed with special primers for collagen type ΧΙ(α1). Real-time RT-qPCR methodologies for different transcriptis with dual hybridization probes were developed on the Light Cycler 1.5 platform (Roche, Germany). All COL11A1 transcripts were measured in 27 cDNA lung tissue specimens in a blinded fashion (8 control and 19 non-small cell lung cancer tissues with known histopathological data). Statistical analysis was performed with the IBM SPSS program.Results: Quantitive RT-PCR revieled that Collagen type XI(α1) was significantly upregulated in NSCLC sampled compared to the control group (p=0.004). There was a significant increase in the mRNA expression levels for Collagen type XI(α1) in early NSCLC stage I (6.7-fold increase). During the follow-up period (1.5±0.5 years), patients who died or has disease relapse had a 8.5-fold increase in Collagen type XI(α1) levels, compared to 3.5-fold increase in patients without disease progression (P=0.009). All 19 NSCLC samples were positive for the general COL11A1 transcript (range 11.2-1198.0 copies/μg total RNA, while five out of eight control samples were negative: mean values were also statistically significantly different (p<0.001). In four tumor samples (21%), no specific COL11A1 transcript was detected. Transcript C was detected in only three tumor samples. Regarding transcripts A and E, 13 out of 19 tumor samples were positive for either one (68%) and 11 for both (58%). Conclusions: The results indicate that increased expression levels of Collagen type XI(α1) in NSCLC may correlate to prognosis. No other statistically significant association of the specific transcripts with histopathological data was observed most probably due to the limited number of samples. As the number of general COL11A1 transcripts/µg exceeds the sum of A+E+C transcripts in all samples, there is opportunity for discovery and identification of other transcripts as well. Further investigation in this biomarker may have the potential to provide a biomarker in selecting patients needing more aggressive treatment approaches.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Perlikos, Fotis
- Περλικός, Φώτης
Subjects
dc:subject × 8Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44203